Tirz 30mg
Supports healthy weight management.
$568
A dual GIP/GLP-1 receptor agonist studied for its effects on glycemic control and significant weight loss.
- Superior glycemic control: significantly reduces HbA1c and increases insulin sensitivity.
- Significant weight loss: average 15–20%+ reduction in body weight; decreases appetite and increases satiety.
- Dual metabolic improvement by mimicking two key hormones, GIP and GLP-1.
- Potential cardiovascular benefits: may lower blood pressure and improve lipid levels.
- Studied for improved liver health (MASH/MASLD) and potential kidney protection.
- Explored for reduced systemic inflammation, better digestion, and improved sleep quality.
1
Dosing schedule
Concentration
10 mg/ml, total 3 ml, total 30 mg
Frequency
Once per week
Dose
Weeks 1-4: start with 2.5 per week. Weeks 5-8: increase to 5 per week. Weeks 9-52: raise to a maximum of 7.5 per week, maintaining that level up to 1 year.
Duration
1 Year
Break
6 Months
No specific break required unless side effects are observed. Figures reflect published research on this compound class, shared for educational context only.
For research use only. Not for human consumption. Not evaluated by the FDA.